RxDoctor Payments Data

Andrea Pezzella, MD

Gynecology · West Columbia, SCNPI 1730157058

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Axonics, Inc. at 49.0% of the total. Reporting peaked in 2024 at $34,096 and has fallen 77.9% since, to $7,525 in 2025. Among gynecology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$99,114in general payments, 2019–2025

Across 629 payments — averaging $157.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$49K
  • Medtronic$18K
  • AbbVie$10K
  • Femselect Inc.$7K
  • Contura, Inc.$4K
  • Coloplast$3K
  • plus $8K from 27 others
$181,541in research payments, 2019–2025

Across 183 payments — averaging $992.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Axonics, Inc.$130K
  • Bluewind Medical$19K
  • Sumitomo Pharma America, Inc.$12K
  • Medtronic$9K
  • Urovant Sciences Inc$6K
  • Coloplast$3K
  • plus $2K from 1 others

What the payments were for

  • Consulting fees$54,84555%
  • Speaking & faculty fees$20,04620%
  • Travel & lodging$7,2417%
  • Food & beverage$16,89217%
  • Education$890%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axonics, Inc.134$48,536
Medtronic(2 entities)144$17,526
AbbVie(2 entities)73$10,180
Femselect Inc.13$7,109
Contura, Inc.3$4,350
Coloplast86$3,472
Escala Medical Inc.8$2,641
Bluewind Medical10$1,650
Boston Scientific15$761
Astellas Pharma US Inc35$602
Sumitomo Pharma America, Inc.17$405
Pfizer14$226
Laborie Medical Technologies Corp.3$212
Antares Pharma, Inc.11$182
Urovant Sciences Inc11$180
Duchesnay USA Incorporated11$143
Valencia Technologies Corporation6$135
Coopersurgical, Inc.3$133
Caldera Medical, Inc1$128
Hologic Sales And Service, LLC5$117
Therapeuticsmd, Inc.4$65
ABC Home Medical Supply, Inc.3$56
180 Medical, Inc.2$49
Millicent US Inc2$44
Mission Pharmacal Company3$42
AMAG Pharmaceuticals, Inc.3$38
Intuitive Surgical2$30
Bayer2$26
Merck1$16
Virtus Pharmaceuticals LLC1$16
Ferring Pharmaceuticals Inc.1$15
Hollister Incorporated1$14
Organon1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$99,114 in reported general payments places this provider in the 95th percentile of 39 gynecology providers in South Carolina.

See all gynecology providers in South Carolina

Medicare billing

Part B allowed, 2024
$545,474
Medicare patients
1,012
Services billed
12,729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron142$95,731
MyrbetriqMirabegron103$61,998
Estradiol299$17,122
Mirabegron ErMirabegron18$7,097
OsphenaOspemifene18$4,233
Fesoterodine Fumarate ErFesoterodine Fumarate45$3,005
Solifenacin Succinate77$2,716
Clobetasol Propionate37$1,535
Methenamine Hippurate21$1,516
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst84$721
ValacyclovirValacyclovir Hcl16$425
ProgesteroneProgesterone, Micronized11$364
Gabapentin40$358
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen95$328
Nystatin12$165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$405$95,731142 claims
Astellas Pharma US IncMyrbetriq$602$61,998103 claims
Duchesnay USA IncorporatedOsphena$143$4,23318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 39 gynecology providers in South Carolina.

Other gynecology in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →